
Jeff Yorio, MD
@jeffyoriomd
Jeff Yorio, MD is a practicing medical oncologist and hematologist at Texas Oncology in Austin, Texas. He is actively involved in clinical trials in Austin.
ID: 738760132473982976
03-06-2016 15:51:55
153 Tweet
258 Followers
301 Following

Great time with the IDEOlogy Health team! Thanks for having me!

⭐️Throughout my career, I have had a front row seat to the impact cancer research makes for patients in clinical trials and beyond. 📍A clinical trial is not a last resort but can be a first option for people facing cancer. #WorldCancerResearchDay #ClinicalTrials Skip Burris, MD

Honored to have been mentored by the amazing Dr. Patrick Hwu who is not only a cancer game changer but a pretty fantastic piano player as well! Check out his band #TheReMissions. DocsWhoRock Sarah Cannon Docs Texas Oncology


Great to have been involved in this trial. It didn't have quite the results we hoped for, but important to keep trying to make our care better. Sarah Cannon Docs Texas Oncology

New vaccine melanoma trial open at Texas Oncology Austin for Stage IIb, IIc, III, IV NED melanoma after surgery. Patients will get pembrolizumab +/- mRNA vaccine personalized to their tumor. Message me if u want more details. AIM at Melanoma Foundation #melanoma clinicaltrials.gov/study/NCT05933…



Jeff Yorio, MD Texas Oncology discussed the unmet needs in this patient group and plans for a phase 3 study of an mRNA vaccine for the treatment of patients with high-risk #melanoma that have already undergone surgery. #MELSM targetedonc.com/view/global-ph…



Kicking off day two of #TexasLung25 with "Advanced NSCLC: Immunotherapy" led by Dr. Dr. Julie Brahmer at 8:30 AM. See you there! hubs.la/Q03g5QrX0 Sheena Bhalla Hossein Borghaei, DO Shirish Gadgeel Ferdinandos Skoulidis Jeff Yorio, MD





What do you get when you combine cutting-edge insights with frontline experience? Faculty like Dr. Jeff Yorio, MD of Texas Oncology—bringing practical insights to #WorldGU25 that you can implement in your community practice. Join us in Nashville, TN, Aug 21–23 for this
